Skip to content
← Back to this collection

PUBLICATIONS · 28916367

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2017 Oct 28
First author
Coleman RL

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2017 Oct 28;390(10106):1948. doi: 10.1016/S0140-6736(17)32702-2.
    note
    Source null
    related pmid
    29115226
    relationship
    Erratum in

Authors and identifiers

  1. name
    Coleman RL
    type
    Author
  2. name
    Oza AM
    type
    Author
  3. name
    Lorusso D
    type
    Author
  4. name
    Aghajanian C
    type
    Author
  5. name
    Oaknin A
    type
    Author
  6. name
    Dean A
    type
    Author
  7. name
    Colombo N
    type
    Author
  8. name
    Weberpals JI
    type
    Author
  9. name
    Clamp A
    type
    Author
  10. name
    Scambia G
    type
    Author
  11. name
    Leary A
    type
    Author
  12. name
    Holloway RW
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Coleman RL
    type
    Author
  2. name
    Oza AM
    type
    Author
  3. name
    Lorusso D
    type
    Author
  4. name
    Aghajanian C
    type
    Author
  5. name
    Oaknin A
    type
    Author
  6. name
    Dean A
    type
    Author
  7. name
    Colombo N
    type
    Author
  8. name
    Weberpals JI
    type
    Author
  9. name
    Clamp A
    type
    Author
  10. name
    Scambia G
    type
    Author
  11. name
    Leary A
    type
    Author
  12. name
    Holloway RW
    type
    Author
bibliography ids
  1. nci-bib-14e148bbd9d916d5e793b382
book metadata
content sha256
3823a18296ff9a7dff7900814456d3475720971808ba59f6f5d0a7e5982be399
document type
citation
dois
  1. 10.1016/S0140-6736(17)32440-6
electronic publication date
display
2017 Sep 12
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28916367
immutable id
pubmed:28916367@3823a18296ff9a7dff7900814456d3475720971808ba59f6f5d0a7e5982be399
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10106
name
Lancet (London, England)
nlm unique id
2985213R
pages
1949-1961
volume
390
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2017 Oct 28;390(10106):1948. doi: 10.1016/S0140-6736(17)32702-2.
    note
    Source null
    related pmid
    29115226
    relationship
    Erratum in
outcomes validated
false
pmid
28916367
provenance
batch id
fb25b16edcb1373b70c1
provider
NCBI PubMed ESummary
record sha256
5a2d0ee69d983aa58469bbe7f8a403cce3a0d6ec712d025c6a80280c76f77ce0
response sha256
182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
retrieved at
2026-09-09T23:47:28.490065+00:00
publication date
display
2017 Oct 28
precision
day
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28916367/
title
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.

Preserved source evidence · Not medical advice